Login | Register

Titan’s Implant For Treating Opioid Dependence – FDA Panel Gives A Cautious ‘Yes’

Probuphine, a buprenorphine subdermal implant formulation for adults with opioid dependence has been given a green light by an FDA Advisory Committee (Panel). The Panel cited a favorable benefit-risk profile and an unmet need. According to Titan Pharmaceuticals Inc., the FDA Panel voted 10 to 4 in favor, with one abstention...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>